152 related articles for article (PubMed ID: 18825854)
1. Preventing venous thromboembolism through risk assessment approaches.
Bonner L; Coker E; Wood L
Br J Nurs; 2008 Jun 26-Jul 9; 17(12):778-82. PubMed ID: 18825854
[TBL] [Abstract][Full Text] [Related]
2. New anticoagulants for prevention and treatment of venous thromboembolism.
Roberts LN; Arya R
Curr Vasc Pharmacol; 2010 May; 8(3):373-82. PubMed ID: 19485902
[TBL] [Abstract][Full Text] [Related]
3. Preventing postsurgical venous thromboembolism: pharmacological approaches.
Tufano A; Coppola A; Cerbone AM; Ruosi C; Franchini M
Semin Thromb Hemost; 2011 Apr; 37(3):252-66. PubMed ID: 21455859
[TBL] [Abstract][Full Text] [Related]
4. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
[TBL] [Abstract][Full Text] [Related]
5. Rivaroxaban for the prevention and treatment of venous thromboembolism.
Turpie AG
Fundam Clin Pharmacol; 2012 Feb; 26(1):33-8. PubMed ID: 21851388
[TBL] [Abstract][Full Text] [Related]
6. Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis.
Alotaibi G; Alsaleh K; Wu C; Mcmurtry MS
Int Angiol; 2014 Aug; 33(4):301-8. PubMed ID: 25056161
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation with {blacktriangledown}dabigatran or{blacktriangledown}rivaroxaban.
Drug Ther Bull; 2009 Oct; 47(10):116-20. PubMed ID: 19809086
[TBL] [Abstract][Full Text] [Related]
8. The management of venous thromboembolism in cancer patients.
Dolan S; Fitch M
Br J Nurs; 2007 Nov 22-Dec 12; 16(21):1308-12. PubMed ID: 18073666
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty.
Borris LC
Arch Orthop Trauma Surg; 2010 May; 130(5):583-9. PubMed ID: 19565250
[TBL] [Abstract][Full Text] [Related]
10. New oral anticoagulants in elderly patients.
Barco S; Cheung YW; Eikelboom JW; Coppens M
Best Pract Res Clin Haematol; 2013 Jun; 26(2):215-24. PubMed ID: 23953909
[TBL] [Abstract][Full Text] [Related]
11. Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
Quinlan DJ; Eriksson BI
Best Pract Res Clin Haematol; 2013 Jun; 26(2):171-82. PubMed ID: 23953905
[TBL] [Abstract][Full Text] [Related]
12. Novel oral anticoagulants for VTE prevention in orthopedic surgery: overview of phase 3 trials.
Friedman RJ
Orthopedics; 2011 Oct; 34(10):795-804. PubMed ID: 21956181
[TBL] [Abstract][Full Text] [Related]
13. An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacement.
Lereun C; Wells P; Diamantopoulos A; Rasul F; Lees M; Sengupta N
J Med Econ; 2011; 14(2):238-44. PubMed ID: 21385145
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinux.
Welzel D; Hull R; Fareed J
Int Angiol; 2011 Jun; 30(3):199-211. PubMed ID: 21617603
[TBL] [Abstract][Full Text] [Related]
15. A logical approach to surgical thromboprophylaxis.
Lepic K; Crowther MA
Curr Opin Hematol; 2009 Sep; 16(5):397-401. PubMed ID: 19550321
[TBL] [Abstract][Full Text] [Related]
16. Improving prevention and treatment of venous thromboembolism: clinical trial results.
Mahan C; Spyropoulos AC
J Med Econ; 2012; 15(4):611-22. PubMed ID: 22372589
[TBL] [Abstract][Full Text] [Related]
17. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Dumont B; Faille D; Ajzenberg N
Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism prophylaxis: the role of the nurse.
Findlay J; Keogh M; Cooper L
Br J Nurs; 2010 Sep 9-22; 19(16):1028-32. PubMed ID: 20852465
[TBL] [Abstract][Full Text] [Related]
19. Novel oral anticoagulants: a review of new agents.
Wanat MA
Postgrad Med; 2013 Jul; 125(4):103-14. PubMed ID: 23933899
[TBL] [Abstract][Full Text] [Related]
20. Knowledge of venous thromboembolism (VTE) prevention among hospitalized patients.
Le Sage S; McGee M; Emed JD
J Vasc Nurs; 2008 Dec; 26(4):109-17. PubMed ID: 19022169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
